Opening up about their below-the-belt health is not a conversation every man wants to have with his doctor, let alone his ...

Women who are experiencing painful micturition may gain some relief by passing urine while in a warm bath. Alternatively, local anesthetic gel may be applied 10 minutes prior to micturition ...

The most common TRAEs (any grade) were hematuria (12.5%), dysuria (12.5%), and micturition urgency, fatigue, nocturia, and ...

Treatment-related adverse events (TRAEs) were observed in 61 (71.8%) patients, with the most frequent being pollakiuria (35.3 ...

Shivering while peeing is not something cute and amusing that only happens to babies. It happens to adults too, more ...

EG-70, a novel, nonviral gene therapy, elicited a 73% complete response at any time for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ.

In the pivotal, randomised, multicentre and double-blind studies, Vibegron showed a favourable risk-benefit profile in treating the urgency, increased micturition [urination] and urge urinary ...

TRAEs occurred in 70 patients (62.5%). The most common TRAEs (≥10%) were bladder spasm, pollakiuria, dysuria, micturition urgency, and hematuria, as of the safety cutoff date of January 31, 2024. “The ...

New data from Phase 2b SunRISe-1 study show rapid achievement of complete response (CR) with 98 percent achieving a CR within 12 weeks1 TAR-200 provides durable CRs in patients with Bacillus ...

A first-in-class interleukin (IL)-15 receptor agonist, the drug is specifically approved in combination with BCG for adults ...

In the phase 3 BOND-003 trial, cretostimogene grenadenorepvec led to durable complete responses over 12 months among patients with high-risk BCG-unresponsive non-muscle-invasive bladder cancer with ...

Johnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study evaluating the efficacy and safety of investigational TAR-200 monotherapy in patients with ...